These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7193623)

  • 1. [Behavioral pharmacology of mianserin hydrochloride, a new antidepressant (author's transl)].
    Kamioka T; Sakai Y
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):533-47. PubMed ID: 7193623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of mianserin on functions of ascending and descending monoaminergic systems, using experimental models (author's transl)].
    Sakai Y; Deguchi T
    Nihon Yakurigaku Zasshi; 1980 Apr; 76(3):213-25. PubMed ID: 6967847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurochemical and electroencephalographical studies on the central actions of mianserin (author's transl)].
    Sakai Y; Matsui Y
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):479-93. PubMed ID: 7203282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lack of antidepressant properties and a potent central antiserotonin activity of Org 8282.
    Przegaliński E; Baran L; Siwanowicz J; Rawłów A
    Pol J Pharmacol Pharm; 1986; 38(4):377-84. PubMed ID: 3774630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavioral effects of quinupramine, a new tricyclic antidepressant].
    Ueki S; Yamamoto T; Shimazoe T; Shibata S; Tani Y; Machida K; Hojo M; Yoshida Y; Tatsumi H
    Nihon Yakurigaku Zasshi; 1988 Jun; 91(6):359-69. PubMed ID: 3417209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. I. Effects on the central nervous system (author's transl)].
    Ochiai T; Yamamura M; Kudo Y; Ishida R
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):347-57. PubMed ID: 7327455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016), a new psychotropic drug with antidepressant activity.
    Tobe A; Yoshida Y; Ikoma H; Tonomura S; Kikumoto R
    Arzneimittelforschung; 1981; 31(8):1278-85. PubMed ID: 7197535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavioral pharmacological properties of the novel antidepressant paroxetine, a selective 5-HT uptake inhibitor].
    Yamamoto T; Shibata S; Shimazoe T; Iwasaki K; Ohno M; Minamoto Y; Furuya Y; Miyamoto K; Watanabe S; Ueki S
    Nihon Yakurigaku Zasshi; 1989 Sep; 94(3):189-206. PubMed ID: 2530142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacological profile of mesterolone.
    Baran L; Przegaliński E
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological action of bromazepam suppository].
    Kasama T; Fujii Y; Aida Y; Mayuzumi K; Mayuzumi Y; Goto M; Gomita Y; Moriyama M; Ichimaru Y
    Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):149-65. PubMed ID: 6133822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavioral pharmacology of a new antidepressant, lopramine].
    Ueki S; Fujiwara M; Inoue K
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):585-607. PubMed ID: 1033109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behavior pharmacology of maprotiline, a new antidepressant].
    Ueki S; Fujiwara M; Inoue K; Kataoka Y; Ibii N
    Nihon Yakurigaku Zasshi; 1975 Nov; 71(8):789-815. PubMed ID: 1240830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
    Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
    Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of beta-amyrin palmitate, a novel centrally acting compound, isolated from Lobelia inflata leaves.
    Subarnas A; Tadano T; Oshima Y; Kisara K; Ohizumi Y
    J Pharm Pharmacol; 1993 Jun; 45(6):545-50. PubMed ID: 8103103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavioral effects of flutoprazepam (KB-509) and its metabolites].
    Ueki S; Sukamoto T; Watanabe S; Yamamoto T; Kataoka Y; Shibata S; Suwandi D; Shibata K; Takano M; Sato Y
    Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):15-30. PubMed ID: 6890927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological studies of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone (M73101). (5) Action of M73101 on the central nervous system (author's transl)].
    Sato M
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):695-706. PubMed ID: 575516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interaction of psychotropic drugs. I. Divergent effect of mianserin on pharmacokinetics and pharmacodynamics of amphetamine.
    Chodera A; Cenajek D; Godlewski J
    Pol J Pharmacol Pharm; 1979; 31(6):609-13. PubMed ID: 575858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavioral and electroencephalographic effects of alprazolam and its metabolites (author's transl)].
    Ueki S; Watanabe S; Yamamoto T; Kataoka Y; Tazoe N; Shibata S; Shibata K; Ohta H; Kawahara K; Takano M; Suwandi D; Lee SC; Liou SY
    Nihon Yakurigaku Zasshi; 1981 May; 77(5):483-509. PubMed ID: 7197658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological properties of lopramine].
    Akashi A; Hashizume T; Tanaka M; Naka S; Suzuki I
    Nihon Yakurigaku Zasshi; 1976 May; 72(4):417-31. PubMed ID: 987974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.